Business

Burcon Announces Non-Brokered Private Placement of Convertible Debentures and Execution of Loan Agreement

Vancouver, British Columbia--(Newsfile Corp. - November 12, 2025) - Burcon NutraScience Corporati...

articleBurcon Nutrascience CorporationNovember 12, 20253/company/burcon-nutrascience-corporation/news/burcon-announces-non-brokered-private-placement-of-convertible-debentures-and-execution-of-loan-agreement
Burcon Announces Non-Brokered Private Placement of Convertible Debentures and Execution of Loan Agreement

About this update from Burcon Nutrascience Corporation

[{"type":"text","content":"Burcon Announces Non-Brokered Private Placement of Convertible Debentures and Execution of Loan AgreementVancouver, British Columbia--(Newsfile Corp. - November 12, 2025) - Burcon NutraScience Corporation (TSX: BU) (OTCQB: BRCNF) (\"Burcon\" or the \"Company\"), a global technology leader in plant-based protein innovation, is pleased to announce a non-brokered private placement of convertible debentures (the \"Convertible Debentures\") for an aggregate principal amount of up to $4 million (the \"Offering\"). Insiders of the Company have committed to participating at a minimum of $2.0 million in principal amount. The Offering is subject to the approval of the Toronto Stock Exchange (\"TSX\").\"We are advancing through a key stage of growth as customer demand translates into commercial expansion,\" said Kip Underwood, Burcon's chief executive officer. \"This financing ensures we have the capital flexibility to execute with speed and accelerate our growth trajectory. The high level of insider participation reaffirms confidence in our strategic direction and the opportunities ahead.\"Each Convertible Debenture will consist of $1,000 principal amount, bear interest at a rate of 15% per annum, payable in full upon maturity, and be unsecured. The principal amount outstanding under the Convertible Debentures and all accrued and unpaid interest thereon will be payable in cash forty-eight (48) months from the date of issuance of the Convertible Debentures. The Convertible Debentures will be convertible at the option of the holder, in whole or in part, into common shares of the Corporation (the \"Shares\") at a conversion price of $2.27 per Share (the \"Conversion Price\"). Accelerated Prepayment or Conversion OptionAt any time after the first anniversary of the issuance date of the Convertible Debentures, if the volume weighted average price of the Shares on the TSX (or such other stock exchange where the Shares principally trade) is above $4.54 (200% of the Conversion Price) for a period of 14 consecutive trading days, the Company may prepay the principal amount outstanding under the Convertible Debentures and any accrued and unpaid interest thereon to the holders of the Convertible Debentures. Upon written notice from the Company of such prepayment, a holder will have thirty (30) days from the date of such notice to accept the prepaymen...

More updates from Burcon Nutrascience Corporation